Used primarily in research as a potent and selective antagonist for the adenosine A2A receptor. This compound is investigated for its potential in treating neurological disorders such as Parkinson’s disease, where modulation of adenosine receptors can help improve motor function and reduce symptoms. It has also been explored in studies related to inflammation, cancer immunotherapy, and psychiatric conditions due to the role of A2A receptors in immune response and neurotransmission. Its ability to cross the blood-brain barrier makes it particularly valuable in central nervous system drug development.